Design and evaluation of fast dissolving oro-dispersible films of metoclopramide hydrochloride using 32 multifactorial designs
dc.Affiliation | October University for modern sciences and Arts (MSA) | |
dc.contributor.author | Yassin G.E. | |
dc.contributor.author | Abass H.A. | |
dc.contributor.other | Department of Pharmaceutics and Industrial Pharmacy | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | Al-Azhar University | |
dc.contributor.other | Egypt; Department of Pharmaceutics | |
dc.contributor.other | Faculty of Pharmacy | |
dc.contributor.other | October University for Modern Science and Arts (MSA) University | |
dc.contributor.other | Egypt | |
dc.date.accessioned | 2020-01-09T20:41:41Z | |
dc.date.available | 2020-01-09T20:41:41Z | |
dc.date.issued | 2016 | |
dc.description | Scopus | |
dc.description.abstract | Objective: The objective of the present work was to develop and optimize fast dissolving orodispersible films containing metoclopramide hydrochloride using 32 multifactorial designs. Methods: The films were prepared by solvent casting method using hydroxypropyl methyl cellulose E5 (HPMC E5) and sodium starch glycolate (SSG) as two independent variables in three levels in concentration 2.5, 3, 3.5% w/wand 1, 1.5, and 2 % respectively. The percent of in vitro drug release (Y1) and the disintegration time (Y2) were chosen and studied as dependent responses. The prepared films were also evaluated for their weight uniformity, thickness, surface pH, drug content, in vitro disintegration time, in vitro drug release, film stability and mechanical properties as folding endurance. Results: All the films were transparent. The films weight (mg) was ranging from 63. 0.78 to 86. 0.82 while the film thickness (mm) and the folding endurance range from 0.22. 0.53, 50.. 0.58 to 0.32. 0.35 and 90. 0.84 respectively. The drug content (mg %) was studied, and it ranges from 98.24. 1.08 to 99.07. 1.02. It was found that the relative standard deviation (% RSD) met the criteria of USP specification for drug content (>6%). In vitro disintegration time was tested; all films satisfied the requirement of disintegration time for fast dissolving dosage form (<1 min), it ranged from 2.24. 1.75 to 3.18. 1.87 sec. The stability studies revealed no significant differences before and after storage for the all formulations. Conclusion: An optimized metoclopramide HCl film was achieved that could be a benefit to a patient suffering from emesis, in which hydroxypropyl methylcellulose (E5) was used as a film forming polymer in its high level (3.5%) in addition to sodium starch glycolate in its high level (2%). 2016 The Authors. | en_US |
dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=19700174810&tip=sid&clean=0 | |
dc.identifier.doi | https://doi.org/ | |
dc.identifier.issn | 9751491 | |
dc.identifier.other | https://doi.org/ | |
dc.identifier.uri | https://t.ly/3GJx5 | |
dc.language.iso | English | en_US |
dc.publisher | Innovare Academics Sciences Pvt. Ltd | en_US |
dc.relation.ispartofseries | International Journal of Pharmacy and Pharmaceutical Sciences | |
dc.relation.ispartofseries | 8 | |
dc.subject | October University for Modern Sciences and Arts | |
dc.subject | University for Modern Sciences and Arts | |
dc.subject | MSA University | |
dc.subject | جامعة أكتوبر للعلوم الحديثة والآداب | |
dc.subject | 32multifactorial designs | en_US |
dc.subject | Fast dissolving orodispersible films | en_US |
dc.subject | Metoclopramide HCL | en_US |
dc.subject | Optimization | en_US |
dc.subject | aspartame | en_US |
dc.subject | citric acid | en_US |
dc.subject | disintegrating agent | en_US |
dc.subject | glycerol | en_US |
dc.subject | hydroxypropylmethylcellulose | en_US |
dc.subject | mannitol | en_US |
dc.subject | metoclopramide | en_US |
dc.subject | polymer | en_US |
dc.subject | starch glycolate sodium | en_US |
dc.subject | Article | en_US |
dc.subject | diffusion | en_US |
dc.subject | dissolution | en_US |
dc.subject | drug design | en_US |
dc.subject | drug dosage form | en_US |
dc.subject | drug release | en_US |
dc.subject | drug stability | en_US |
dc.subject | endurance | en_US |
dc.subject | factorial analysis | en_US |
dc.subject | humidity | en_US |
dc.subject | oro dispersible film | en_US |
dc.subject | pH | en_US |
dc.subject | process optimization | en_US |
dc.subject | regression analysis | en_US |
dc.subject | tablet disintegration time | en_US |
dc.subject | thickness | en_US |
dc.subject | weight variation | en_US |
dc.title | Design and evaluation of fast dissolving oro-dispersible films of metoclopramide hydrochloride using 32 multifactorial designs | en_US |
dc.type | Article | en_US |
dcterms.isReferencedBy | Al-Hezaimi, K., Al-Askar, M., Selamhe, Z.F.J.H., Alsarra, I.A., Wang, H.L., Evaluation of novel adhesive film containing ketorolac for post-surgery pain control: A safety and efficacy study (2011) Periodontal, 82, pp. 963-968; Vasisht, N., Gever, L.N., Tagarro, I., Finn, A.L., Single-dose pharmacokinetics offentanylbuccal soluble film (2010) Pain Med, 11, pp. 1017-1023; Finn, A.L., Hill, W.C., Tagarro, I., Gever, L.N., Absorption and tolerability of fentanyl buccalsoluble film (FBSF) in patients with cancer in the presence of oral mucositis (2011) J Pain Res, 4, pp. 245-251; Nishimura, M., Matsuura, K., Tsukioka, T., Yamashita, H., Inagaki, N., Sugiyama, T., In vitro and in vivo characteristics of prochlorperazine oral disintegratingfilm (2009) Int J Pharm, 98, pp. 102-368; Kunte, S., Tandale, P., Fast dissolving strips: A novel approach for the delivery of verapamil (2010) J Pharm BioAllied Sci, 2, pp. 325-328; Arya, A., Handra, A., Sharma, V., Pathak, K., Fast dissolving oral films: An innovative drug delivery and dosage form (2010) Int Chem Technol Res, 2, pp. 576-583; Kelly, H.W., Murphy, S., Beta-adrenergic agonists for acute severe asthma (1992) Ann Pharmacother, 26, pp. 81-91; Patel, R.S., Poddar, S.S., Development and characterization of mucoadhesivebuccal patches of salbutamol sulphate (2009) Curr Drug Delivery, 6, pp. 140-144; Olsson, A., Sheng, Y., Kjellen, E., Pero, R.W., In vivo tumor measurement of DNA damage, DNA repair and DNA pools as indicators of radiosensitization by metochlopramide (1995) Carcinogenesis, 16, pp. 1029-1035; Dollery, C., (1999) Therapeutic drugs, pp. M132-M136. , 2nd ed. Churchill livingstone, Toronto; Harrington, R.A., Hamilton, C.W., Brogden, R.N., Metoclopramide an updated review of its pharmacological properties and clinical use (1983) Drugs, 25, pp. 451-494; Cilurzo, F., Cupone, I.E., Minghetti, P., Selmin, F., Montanari, L., Fast dissolving films made of maltodextrins (2008) Eur J Pharm Biopharm, 70, pp. 895-900; Mashru, R.C., Sutariya, V.B., Sankalia, M.G., Parikh, P.P., Development and evaluation of fast-dissolving film of salbutamol sulphate (2005) Drug Dev Ind Pharm, 31, pp. 25-34; Mahesh, A., Shastri, N., Sadanandam, M., Development of taste masked fast disintegrating films of levocetirizine-dihydrochloride for oral use (2010) Curr Drug Delivery, 7, pp. 21-27; Choudhary, D., Patel, V., Patel, H., Formulation and evaluation of quick dissolving film of levecetrizine di hydrochloride (2011) Int J Pharm Technol, 3, pp. 1740-1749; (2007) USP30-NF25, the United States Pharmacopoeia-National Formulary and its supplements; Hoffmann, E.M., Breitenbach, A., Breitkreutz, J., Advances in orodispersible films for drug delivery (2011) Expert Opin Drug Delivery, 8, pp. 299-316; Misra, R., Amin, A., Formulation development of taste-masked rapidly dissolving films of citrizine hydrochloride (2009) Pharm Technol, 33, pp. 48-56; Vasantha, P.V., Puratchikody, A., Mathew, S.T., Balaraman, A.K., Development and characterization of Eudragit based mucoadhesivebuccal patches of salbutamol sulfate (2011) Saudi Pharm J, 19, pp. 207-214; Chaughary, H., Gauri, S., Rathee, P., Kumar, V., Development and optimizationof fast dissolving oro-dispersible films of granisetron HCl using Box-Behnken statistical design (2013) Bull Faculty Pharm Cairo University, 51, pp. 193-201; Hill, S.W., Varker, A.S., Karlage, K., Myrdal, P.B., Analysis of drug content and weight uniformity for half-tablets of 6 commonly split medications (2009) J Manag Care Pharm, 15, pp. 253-261; Raju, S., Sandeep Reddy, P., Anirudh Kumar, V., Deepthi, A., Sreeramulu Reddy, K., Madhava Reddy, P.V., Flash release oral films of metoclopramide hydrochloride for pediatric use: Formulation and in vitro evaluation (2011) J Chem Pharm Res, 3, pp. 636-646; Kumar, P., Kumar, S., Kumar, A., Chander, M., Physicochemical characterization of solid dispersion of cefdinir with PVP K-30 and PEG4000 (2010) Int J Pharm Sci Nanotechnol, 3, pp. 948-956; Patel, T., Patel, L.D., Patel, T., Makwana, S., Patel, T., Enhancement of dissolution of fenofibrate by solid dispersion technique (2010) Int Res Pharm Sci, 1, pp. 127-132 | |
dcterms.source | Scopus |